These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 10543414

  • 1. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
    Heilmann P, Heide J, Hundertmark S, Schöneshöfer M.
    Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
    [Abstract] [Full Text] [Related]

  • 2. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M, Tanaka A, Hino K, Takamura H, Hirano T, Oka K, Kanazawa M, Miwa T, Notoya Y, Niitsuma T, Hayashi T.
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [Abstract] [Full Text] [Related]

  • 3. Effect of glycyrrhizin on cortisol metabolism in humans.
    Soma R, Ikeda M, Morise T, Miyamori I, Takeda R.
    Endocr Regul; 1994 Mar; 28(1):31-4. PubMed ID: 7949011
    [Abstract] [Full Text] [Related]

  • 4. A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid.
    Ploeger B, Mensinga T, Sips A, Deerenberg C, Meulenbelt J, DeJongh J.
    Toxicol Appl Pharmacol; 2001 Jan 01; 170(1):46-55. PubMed ID: 11141355
    [Abstract] [Full Text] [Related]

  • 5. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
    Yokokawa A, Takasaka T, Shibasaki H, Kasuya Y, Kawashima S, Yamada A, Furuta T.
    Steroids; 2012 Oct 01; 77(12):1291-7. PubMed ID: 22850318
    [Abstract] [Full Text] [Related]

  • 6. The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers.
    MacKenzie MA, Hoefnagels WH, Jansen RW, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1990 Jun 01; 70(6):1637-43. PubMed ID: 2161425
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man.
    Palermo M, Armanini D, Shackleton CH, Sorba G, Cossu M, Roitman E, Scaroni C, Delitala G.
    Exp Clin Endocrinol Diabetes; 2002 Sep 01; 110(6):272-6. PubMed ID: 12373630
    [Abstract] [Full Text] [Related]

  • 9. Alteration of the activity of the 11beta-hydroxysteroid dehydrogenase in pregnancy: relevance for the development of pregnancy-induced hypertension?
    Heilmann P, Buchheim E, Wacker J, Ziegler R.
    J Clin Endocrinol Metab; 2001 Nov 01; 86(11):5222-6. PubMed ID: 11701681
    [Abstract] [Full Text] [Related]

  • 10. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo.
    Best R, Walker BR.
    Clin Endocrinol (Oxf); 1997 Aug 01; 47(2):231-6. PubMed ID: 9302399
    [Abstract] [Full Text] [Related]

  • 11. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G, Pascoe L, Marc JM, Caillette A, Krozowski Z, Corvol P, Fiet J.
    Arch Mal Coeur Vaiss; 1997 Aug 01; 90(8):1111-5. PubMed ID: 9404418
    [Abstract] [Full Text] [Related]

  • 12. Glycyrrhetinic acid attenuates vascular smooth muscle vasodilatory function in healthy humans.
    Sobieszczyk P, Borlaug BA, Gornik HL, Knauft WD, Beckman JA.
    Clin Sci (Lond); 2010 Aug 05; 119(10):437-42. PubMed ID: 20515440
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF, Monson JP.
    Clin Endocrinol (Oxf); 1998 Feb 05; 48(2):153-62. PubMed ID: 9579226
    [Abstract] [Full Text] [Related]

  • 15. Apparent mineralocorticoid excess.
    Benediktsson R, Edwards CR.
    J Hum Hypertens; 1994 May 05; 8(5):371-5. PubMed ID: 8064785
    [Abstract] [Full Text] [Related]

  • 16. Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats.
    Shimoyama Y, Hirabayashi K, Matsumoto H, Sato T, Shibata S, Inoue H.
    J Pharm Pharmacol; 2003 Jun 05; 55(6):811-7. PubMed ID: 12841942
    [Abstract] [Full Text] [Related]

  • 17. The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients.
    Ulick S, Wang JZ, Hanukoglu A, Rösler A.
    J Lab Clin Med; 1993 Dec 05; 122(6):673-6. PubMed ID: 8245686
    [Abstract] [Full Text] [Related]

  • 18. Apparent mineralocorticoid excess.
    Funder JW.
    Endocrinol Metab Clin North Am; 1995 Sep 05; 24(3):613-21. PubMed ID: 8575412
    [Abstract] [Full Text] [Related]

  • 19. Acute intrarenal administration of cortisol has no effect on renal blood flow in hypertensive individuals.
    van Uum SH, Houben AJ, Hermus AR, Kroon AA, Walker BR, Sweep CG, Smits P, de Leeuw PW, Lenders JW.
    J Hypertens; 2002 Nov 05; 20(11):2275-83. PubMed ID: 12409967
    [Abstract] [Full Text] [Related]

  • 20. Cortisol metabolism in the postoperative period after cardiac surgery.
    Vogeser M, Felbinger TW, Röll W, Jacob K.
    Exp Clin Endocrinol Diabetes; 1999 Nov 05; 107(8):539-46. PubMed ID: 10612485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.